China Dominates APAC’s Emergence As Global Trials Hub

39% Of Total Trial Starts In ’23

23 Dec 2024

Asia-Pacific continues to solidify its position as a key location for clinical trials, with China in particular dominating such activity in the region, and increasingly globally, a Citeline White Paper shows.

The APAC region has emerged as a leader in the global clinical trial landscape, attributable to several key factors including a large, diverse patient population with a large proportion of treatment-naïve people, cost effectiveness in conducting clinical trials and a favorable regulatory environment.

So concludes a new White Paper from Citeline Clinical, Exploring the Asia-Pacific Clinical Trials Landscape:...